Synthetic process

US11332442B2 · kind B2 · utility

Assignees

• Bristol-Myers Squibb Company · US
• Syngene International Limited · IN

Inventors

• William P. Gallagher · Clarksburg, US
• John R. Coombs · Tinton Falls, US
• Carlos A. Guerrero · San Diego, US
• David Marcoux · Pennington, US
• Qing Shi · Princeton, US
• Candice Lee Joe · New Brunswick, US
• Sanjeewa Rupasinghe · Pennington, US
• Jason J. Zhu · East Brunswick Township, US
• Srinivas Kalidindi · Bengaluru, IN
• Sathasivam Shunmugaraj · Hosur, IN
• Moorthy Kandasamy · Tiruvannamalai, IN
• Siva Sankar Bondigela · Bengaluru, IN
• Rajappa Vaidyanathan · Bengaluru, IN
• Shankar Tulsidas Tendulkar · Yellapura, IN
• Sankar Kuppusamy · Neyveli, IN
• Francisco Gonzalez-Bobes · New Brunswick, US

Key dates

• Filing date: Aug 12, 2020
• Grant date: May 17, 2022
• Expiry date: Aug 12, 2040

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C317/24
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention generally relates to a process for preparing compounds, including Compound of Formula (I), useful as key intermediates in the preparation of compounds having RORγt antagonist properties.